Staying in Glucose Range Matters: New Study Links Declining Control to Complications

Researchers tracked 246 adults with Type 1 diabetes (median age 40, average time since diagnosis 24 years) using continuous glucose monitor data collected over five years. The study looked at whether glucose patterns predicted microvascular complications—damage to small blood vessels that can harm the eyes, kidneys, and nerves.

The researchers defined three major complications: diabetic kidney disease (measured by protein in urine, kidney function, or use of blood pressure medications), severe eye disease (proliferative retinopathy, macular damage, or blindness), and nerve damage (detected by monofilament testing or nerve conduction studies).

The study found a meaningful link between declining time in range (TIR)—the percentage of time glucose stayed within target—and the five-year risk of developing microvascular complications. In simpler terms, adults whose time in range got worse over the study period were more likely to develop kidney, eye, or nerve problems.

This suggests that glucose control patterns tracked by CGM devices carry predictive power beyond a single A1C test, offering a more detailed picture of long-term risk.

For adults managing Type 1 diabetes, this research reinforces that consistency in glucose control over months and years is tied to avoiding serious complications. While no single high or low reading determines health outcomes, the trend of how much time glucose spends in range appears meaningful.

The findings may also help clinicians and researchers use CGM data more strategically—not just to manage day-to-day blood sugar, but to identify people at higher risk for complications earlier, when interventions might help prevent or delay damage.

This was an observational study, meaning researchers watched what happened without testing a new treatment. That's a strength for understanding real-world patterns, but it cannot prove that declining time in range directly causes complications—only that the two are connected.

The study included 246 adults at a single tertiary center, so results may not apply equally to all people with Type 1 diabetes or all healthcare settings. Larger, diverse studies would help confirm whether these patterns hold across different populations and care environments.

Origin: medicaldialogues.in (News report). Evidence: News report, corroborated with 1 indexed study. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.